Ray Dalio
CORT icon

Ray Dalio’s Corcept Therapeutics CORT Stock Holding History

Ray Dalio’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.01M Buy
57,602
+19,180
+50% +$1.16M 0.02% 482
2026
Q1 		$1.55M Sell
38,422
-240,578
-86% -$9M 0.01% 708
2025
Q4 		$9.7M Sell
279,000
-26,946
-9% -$2.12M 0.04% 364
2025
Q3 		$25.4M Buy
+305,946
New +$22.1M 0.1% 169

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Ingalls & Snyder LLC
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Parallel Advisors
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ray Dalio's CORT Position: Q2 2026 in Review

Ray Dalio increased its Corcept Therapeutics (CORT) stake by 50% in Q2 2026, buying an estimated $1.16M and bringing the position to 57,602 shares worth $5.01M. The position accounts for 0.02% of the portfolio, ranked #482.

Ray Dalio first reported a position in CORT in Q3 2025 and has held it in 4 quarters since. The position peaked at $25.4M in Q3 2025. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Ray Dalio held 57,602 shares of Corcept Therapeutics worth $5.01M as of Q2 2026.
  • Ray Dalio bought 19,180 Corcept Therapeutics shares in Q2 2026, an estimated $1.16M.
  • Corcept Therapeutics made up 0.02% of Ray Dalio's portfolio in Q2 2026, its #482 holding.
  • Ray Dalio first reported a position in Corcept Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Ray Dalio's Corcept Therapeutics position peaked at $25.4M in Q3 2025.
  • 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.